BhuvaneswariRamaswamyMD

Oncology • Columbus, OH

Professor, Internal Medicine, Ohio State University College of Medicine

Join to view full profile

Dr. Ramaswamy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ramaswamy's full profile

Already have an account?

Office
1145 Olentangy River Rd
Ste 4000
Columbus, OH 43212
Phone+1 614-293-0066

Fax+1 614-293-7264

Education & Training

Mount Carmel Health SystemResidency, Internal Medicine, 2000 - 2002
Kilpauk Medical CollegeClass of 1987

Certifications & Licensure

OH State Medical License 2002 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2009 Feb 01
Terminated
Phase 2
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer Start of enrollment: 2010 May 26
Completed
Phase 2
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer Start of enrollment: 2010 Nov 16
Completed
Phase 1
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 31
Completed
Phase 2
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Completed
Phase 3
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery Start of enrollment: 2017 Feb 16
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

12 citations
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.
Daniel G. Stover, Raquel E. Reinbolt, Elizabeth J. Adams, Sarah Asad, Katlyn Tolliver
JCO Precision Oncology. 2019-11-18
8 citations
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine P...
Robert Wesolowski, Daniel G. Stover, Maryam B. Lustberg, Abigail B. Shoben, Meng Zhao
The Oncologist. 2020-08-01
22 citations
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.
Sagar Sardesai, Mohamed Badawi, Ewa Mrozek, Evan Morgan, Mitch A. Phelps
Investigational New Drugs. 2020-01-17

Press Mentions

Virtual Cultivating a Cure a SuccessAugust 21st, 2020
Clinical Challenges: Sequencing in Second-Line Therapy in HR-Positive Breast CancerOctober 18th, 2019
Breastfeeding Reduces Breast Cancer Risk, Ohio State Research ShowsMay 16th, 2019
Join now to see all

Other Languages

Tamil